August 13, 2002FeaturesClinical Trial Data Management: Tortured by Paper
COVER STORY Reams of paper stuffed into boxes and shipped to the FDA by the truckload is probably not the best approach to drug approval. But what is the solution?
By Mark D. UehlingThe Proteomics Odyssey
Efforts to map the constellation of proteins in humans gather momentum as companies vie to provide tools to capitalize on the potential of proteomics.
By Malorye BrancaNews·Analysis Adding Missing Links for Data IntegrationPolitics Keeps Top FDA Post VacantLinking Genes and BehaviorPotential Patent Obstacles on HorizonHDF Posts Data Bonanza OnlineGNS Bares World’s Most Complex Cancer Cell ModelNo Reformatting RequiredHelping Patients Add Up the OddsBeyond BioinformaticsHorizonsCaroline Kovac: Making Standards Work for Informatics FieldCONVERSATION IBM's life science leader says collaboration is the key for the troubled industry.Think Blue ... AgainINNOVATION IBM's petaflop computer, Blue Gene, is being designed with bioscience in mind.Let's get SmallINNOVATION Nanotechnology raises the bar for semiconductors as chips near single-digit nanometer proportions.Improving Life Science SoftwareGUEST COMMENTARY Technology companies need to play catch-up to biosciences' needs.Cracking the Compensation CodeGUEST COMMENTARY A recent study suggests compensation for bioscience CEOs is on target.Columns & DepartmentsFirst Base | Kevin Davies
Howard Hughes Medical Institute Offers a Helping HandBusiness Watch | Mark Hall · IDC
Clusters and Candy WrappersPaper View | Kevin Davies
Curtailing the Cancer Cell New Products
JMP Upgrade Released · Xpogen Offers Data Analysis Tool · Sun Expands Grid Computing on Enterprise LevelThe Dodge Retort | John Dodge
Innovation: The PC's EnemyLetters